Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan
· Delayed Price · Currency is TWD 35.55
-1.25 (-3.40%)
At close: Mar 9, 2026
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 11.69 billion as of March 9, 2026. Its market cap has decreased by -30.70% in one year.
Market Cap
11.69B
Enterprise Value
10.31B
Revenue
594.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.55
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 11.69B, an increase of 312.24%. That is a compound annual growth rate of 14.31%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 11.86B |
| Ever Supreme Bio Technology | 12.66B |
| TCM Biotech International | 14.02B |
| AP Biosciences | 14.46B |
| TaiMed Biologics | 14.62B |
| Gongwin Biopharm Holdings | 9.81B |
| PharmaEngine | 8.78B |
| TaiGen Biopharmaceuticals Holdings | 8.68B |